Patent ID: 8017596

Claim:
A method for modulating γ9δ2 T lymphocyte proliferation comprising contacting a γ9δ2 T lymphocyte with, or administering to a subject in need thereof, an effective amount of a compound of formula (I): wherein A is C 5 -C 50 alkyl, alkenyl, or alkynyl, which may be linear, branched, or cyclic, and may optionally be substituted by: one or more substituents selected from the group consisting of a carboxylic acid, an ester, an amide, a nitrile, a hydroxyl, an aldehyde, a ketone, a halogen, an amine, a thiol, a thio-ketone, an episulfide, a selenol, a seleno-ketone, a sulfide, a sulfone, and a sulfoxide; n is an integer from 1 to 4, X is hydrogen , H + , Na + , NH 4 + , K + , Li + , (CH 3 CH 2 ) 3 NH + or an enzyme labile ester, B is X or is a group: wherein X and A are as defined above.